AbbVie <ABBV.N>: Bofa Global Research Raises Price Objective to $282.00 From $276.00
ABBV•Related News
Citigroup upgrades C.H. Robinson to 'buy' as freight market conditions improve
CHRW•
Fold - Enters Common Stock Purchase Agreement With Roth Principal Investments On Sept 4, 2026 - SEC Filing
FLD•
Vale says no new facts on potential Vale Base Metals IPO after media report
VALE•
Cyngn realigns organization to accelerate enterprise growth, AI-driven efficiency
CYN•
Erasca to present at Morgan Stanley Global Healthcare Conference
ERAS•